The Lab Rats

The group is developing novel immunotherapies using the Adeno-associated virus (AAV) gene-therapy platform that are capable of not only preventing development of disease, but can also stop preexisting (reverse) disease in mouse models of Multiple Sclerosis.


Brad Hoffman

Dr. Hoffman is an Associate Professor and cellular immunologist with a major interest in immune modulation and tolerance induction using adeno-associated virus (AAV) gene therapy. Dr. Hoffman earned his Ph.D. in Immunology from Temple University School of Medicine in 2006. He subsequently performed postdoctoral research in gene therapy at University of Florida.

Brad Hoffman

UF Pediatric News

AAP, CDC recommend COVID-19 vaccine for ages 12 and older

The AAP recommends adolescents ages 12 and older get vaccinated against COVID-19 now that federal health officials have signed off on the Pfizer-BioNTech vaccine for these ages.

Drs. Kelly & Thompson begin prestigious fellowship for women leaders

For UF Health pediatricians Maria N. Kelly, M.D., and Lindsay A. Thompson, M.D., medicine was always a career certainty. For years, they have embraced the special challenges of academic medicine — treating…

UF Health, Florida Department Of Health In Alachua County Address Vaccine Concerns

Dr. Kathleen Ryan, UF Health associate division chief for pediatric infectious disease, said although pregnant women were not included in the vaccine trials, the CDC is still recommending pregnant women…

Call for Abstracts | 2021 Pediatric Medical Student Research Forum

Saturday, September 4, 2021Disney’s Yacht Club Resort in Orlando, Florida We are excited to invite everyone back to Disney for the 7th Annual Pediatric Research Forum for Medical Students! This program…